$NUS
NU SKIN ENTERPRISES, INC.

2020 Q2 Form 10-Q Financial Statement

#000114036120010880 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $612.4M $518.0M $623.6M
YoY Change -1.79% -16.93% 1.2%
Cost Of Revenue $154.1M $125.8M $146.7M
YoY Change 0.06% -14.23% 0.25%
Gross Profit $458.3M $392.2M $477.0M
YoY Change -2.39% -17.76% 1.5%
Gross Profit Margin 74.84% 75.72% 76.48%
Selling, General & Admin $400.2M $355.7M $408.3M
YoY Change 1.24% -12.89% -0.63%
% of Gross Profit 87.32% 90.68% 85.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.26M $19.10M $19.61M
YoY Change -4.14% -2.61% 3.74%
% of Gross Profit 3.99% 4.87% 4.11%
Operating Expenses $400.2M $355.7M $408.3M
YoY Change 1.24% -12.89% -0.63%
Operating Profit $58.07M $36.57M $68.65M
YoY Change -21.74% -46.74% 16.36%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.581M -$6.174M -$2.848M
YoY Change -147.53% 116.78% -337.33%
Pretax Income $59.66M $30.39M $65.81M
YoY Change -15.83% -53.82% 9.31%
Income Tax $17.80M $10.70M $22.80M
% Of Pretax Income 29.84% 35.21% 34.65%
Net Earnings $41.90M $19.73M $43.00M
YoY Change -9.5% -54.12% 21.13%
Net Earnings / Revenue 6.84% 3.81% 6.9%
Basic Earnings Per Share $0.36 $0.78
Diluted Earnings Per Share $807.3K $0.36 $0.77
COMMON SHARES
Basic Shares Outstanding 51.90M 55.06M 55.44M
Diluted Shares Outstanding 55.10M 56.13M

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $386.3M $361.7M $318.3M
YoY Change 4.86% 13.63% -25.99%
Cash & Equivalents $375.5M $352.6M $310.3M
Short-Term Investments $10.80M $9.100M $8.000M
Other Short-Term Assets $73.20M $66.50M $67.70M
YoY Change 11.59% -1.77% 1.5%
Inventory $262.0M $257.5M $304.3M
Prepaid Expenses
Receivables $64.40M $43.97M $57.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $785.8M $729.6M $747.7M
YoY Change -0.3% -2.42% -10.33%
LONG-TERM ASSETS
Property, Plant & Equipment $587.5M $597.2M $562.9M
YoY Change 32.62% 6.09% 10.7%
Goodwill $196.6M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $148.4M $145.2M $161.0M
YoY Change -7.46% -9.81% 11.5%
Total Long-Term Assets $1.009B $1.017B $1.007B
YoY Change 0.58% 0.92% 7.07%
TOTAL ASSETS
Total Short-Term Assets $785.8M $729.6M $747.7M
Total Long-Term Assets $1.009B $1.017B $1.007B
Total Assets $1.795B $1.746B $1.755B
YoY Change 0.19% -0.5% -1.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.70M $39.90M $52.30M
YoY Change 6.49% -23.71% -16.05%
Accrued Expenses $338.0M $285.2M $304.8M
YoY Change 10.28% -6.43% -1.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $95.00M $95.00M $45.00M
YoY Change 59.66% 111.11% -87.59%
Total Short-Term Liabilities $484.6M $420.1M $402.0M
YoY Change 16.91% 4.5% -45.26%
LONG-TERM LIABILITIES
Long-Term Debt $319.9M $327.2M $356.2M
YoY Change -8.34% -8.14% 231.97%
Other Long-Term Liabilities $197.9M $198.5M $185.6M
YoY Change 2.75% 6.95% 38.71%
Total Long-Term Liabilities $517.8M $525.7M $541.8M
YoY Change -4.39% -2.97% 124.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $484.6M $420.1M $402.0M
Total Long-Term Liabilities $517.8M $525.7M $541.8M
Total Liabilities $1.003B $945.8M $943.9M
YoY Change 4.85% 0.2% -3.24%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $792.0M $800.5M $811.2M
YoY Change
Total Liabilities & Shareholders Equity $1.795B $1.746B $1.755B
YoY Change 0.19% -0.5% -1.1%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $41.90M $19.73M $43.00M
YoY Change -9.5% -54.12% 21.13%
Depreciation, Depletion And Amortization $18.26M $19.10M $19.61M
YoY Change -4.14% -2.61% 3.74%
Cash From Operating Activities $97.10M $69.00M -$8.200M
YoY Change 17.41% -941.46% 645.45%
INVESTING ACTIVITIES
Capital Expenditures $9.305M $19.39M $13.77M
YoY Change -39.77% 40.84% -208.39%
Acquisitions
YoY Change
Other Investing Activities $0.00 $200.0K -$4.400M
YoY Change -100.0% -104.55% -85.23%
Cash From Investing Activities -$9.300M -$19.20M -$18.10M
YoY Change -42.94% 6.08% -57.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -69.50M -23.00M -53.00M
YoY Change 407.3% -56.6% -276.67%
NET CHANGE
Cash From Operating Activities 97.10M 69.00M -8.200M
Cash From Investing Activities -9.300M -19.20M -18.10M
Cash From Financing Activities -69.50M -23.00M -53.00M
Net Change In Cash 18.30M 26.80M -79.30M
YoY Change -65.28% -133.8% 483.09%
FREE CASH FLOW
Cash From Operating Activities $97.10M $69.00M -$8.200M
Capital Expenditures $9.305M $19.39M $13.77M
Free Cash Flow $87.80M $49.61M -$21.97M
YoY Change 30.55% -325.87% -289.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43973000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50378000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
518028000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
146664000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
623623000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
125793000
CY2020Q1 us-gaap Gross Profit
GrossProfit
392235000
CY2020Q1 us-gaap Selling Expense
SellingExpense
206042000
CY2019Q1 us-gaap Selling Expense
SellingExpense
249708000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
149628000
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-12421
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Provo
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84601
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
NU SKIN ENTERPRISES, INC.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0565309
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
75 West Center Street
CY2020Q1 dei City Area Code
CityAreaCode
801
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
345-1000
CY2020Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $.001 par value
CY2020Q1 dei Trading Symbol
TradingSymbol
NUS
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51899031
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
355670000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
408306000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
36565000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
68653000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6174000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2848000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30391000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65805000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22803000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
19730000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
43002000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55059000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55436000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55101000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56128000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
19730000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
43002000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
875289000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
19730000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14997000
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
60886000
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
100000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-1407000
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001021561
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 us-gaap Gross Profit
GrossProfit
476959000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
158598000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10661000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-3000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-145000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14997000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4140000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4733000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47142000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3455000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
20686000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
800498000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
781867000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
43002000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4140000
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
825000
CY2019Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
200000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2156000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5041000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
20531000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
811195000
CY2020Q1 us-gaap Nature Of Operations
NatureOfOperations
<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z114de76cffb541b598e5520e0a2b2b81" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.</td> <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">The Company</span></div></td> </tr> </table> <div><br/></div> <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, a leading global direct selling company, being the primary operating unit.  Nu Skin develops and distributes premium-quality, innovative personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services.  The Company reports revenue from </span>nine<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;"> segments, consisting of its </span>seven<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;"> geographic Nu Skin segments</span><span style="background-color: #FFFFFF; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">—</span><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Mainland China; South Korea; Southeast Asia, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand and Vietnam; Americas/Pacific, which includes Australia, Canada, Latin America, New Zealand and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa (“EMEA”), which includes several markets in Europe as well as Israel, Russia and South Africa</span><span style="background-color: #FFFFFF; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">—its Manufacturing segment, which includes manufacturing and packaging subsidiaries; and its </span>Grow Tech segment, which focuses on developing controlled-environment agriculture technologies<span style="background-color: #FFFFFF; font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;"> (the Company’s subsidiaries operating within each segment are collectively referred to as the “Subsidiaries”).</span></div>
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.048
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2020Q1 nus Lessee Operating Lease Lease Not Yet Commenced Liability Not Accrued
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityNotAccrued
100000
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
409300000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
13136000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
12861000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
974000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1052000
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
45000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
52000
CY2020Q1 us-gaap Sublease Income
SubleaseIncome
1131000
CY2019Q1 us-gaap Sublease Income
SubleaseIncome
1593000
CY2020Q1 us-gaap Lease Cost
LeaseCost
13024000
CY2019Q1 us-gaap Lease Cost
LeaseCost
12372000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
13367000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
14377000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21822000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
128704000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
37395000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
43231000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
28941000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
20119000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
15597000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
30881000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
176164000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
27563000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
148601000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
36565000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
68653000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6174000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2848000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10700000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22800000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.351
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.347
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
19500000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
20000000.0
CY2019Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
60000000.0
CY2019Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
6000000.0
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
9
CY2020Q1 nus Number Of Geographic Reportable Segments
NumberOfGeographicReportableSegments
7
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
518028000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
623623000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30391000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65805000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19095000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19607000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19387000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13765000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
48600000
CY2018 us-gaap Restructuring Charges
RestructuringCharges
22100000
CY2018 us-gaap Severance Costs1
SeveranceCosts1
20100000
CY2018 us-gaap Other Restructuring Costs
OtherRestructuringCosts
2000000.0
CY2018Q4 us-gaap Restructuring Reserve
RestructuringReserve
15462000
CY2019Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
15046000
CY2019Q1 us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
-416000
CY2019Q1 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2020Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
0

Files In Submission

Name View Source Status
0001140361-20-010880-index-headers.html Edgar Link pending
0001140361-20-010880-index.html Edgar Link pending
0001140361-20-010880.txt Edgar Link pending
0001140361-20-010880-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
ex4_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
nus-20200331.xsd Edgar Link pending
nus-20200331_cal.xml Edgar Link unprocessable
nus-20200331_def.xml Edgar Link unprocessable
nus-20200331_lab.xml Edgar Link unprocessable
nus-20200331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending